Skip to content
Safety information · Internal patient-safety page

Liraglutide safety summary

Liraglutide is a GLP-1 receptor agonist that acts on the brain's appetite centres and slows stomach emptying, so you feel full sooner and eat less. Unlike its weekly cousins, it is injected once a day. It is indicated for chronic weight management alongside a reduced-calorie diet and increased physical activity.

Liraglutide

What it's used for

  • Once-daily self-injection into the thigh, abdomen or upper arm, at any time of day but ideally at the same time each day.
  • The dose is built up week by week to the maintenance dose, to limit digestive side effects.
  • Works alongside diet and physical activity. It does not replace lifestyle change.

Most common side effects

  • Very common (more than 1 in 10 people): nausea, vomiting, diarrhoea, constipation and headache.
  • Common: tiredness, indigestion and abdominal pain.
  • Common: mild injection-site reactions.
  • Low blood sugar when combined with insulin or sulfonylureas, not a typical risk of liraglutide alone.

Serious side effects: stop and seek care

  • Severe abdominal pain radiating to the back (possible pancreatitis): stop injecting and seek urgent care.
  • Gallbladder problems: sudden pain in the upper right abdomen, fever, yellowing of skin or eyes.
  • Severe dehydration from prolonged vomiting or diarrhoea: risk of acute kidney injury.
  • A racing heartbeat that doesn't settle at rest.
  • Severe allergic reaction (rash, swelling, difficulty breathing).

Who should not take it

  • Allergy to liraglutide or any ingredient of the injection.
  • Pregnancy, planning a pregnancy, or breastfeeding.
  • Not to be combined with other GLP-1 receptor agonists.
  • Not recommended in severe kidney or liver impairment, or in severe heart failure.
  • Tell your doctor about any history of pancreatitis or gallstones.

Interactions to flag

  • Insulin and sulfonylureas: risk of low blood sugar; doses may need adjusting.
  • Oral medicines with a narrow margin (e.g. warfarin): closer monitoring is sensible when starting.
  • Tell your doctor about every diabetes medicine you take before the first injection.

Message us in the app chat if you notice any of these

  • Severe or persistent abdominal pain: same day.
  • Vomiting that stops you keeping fluids down for more than 24 hours.
  • Pain in the upper right abdomen, fever or yellowing of the skin.
  • A pregnancy or a positive pregnancy test: stop injecting and contact us.
AEMPS CIMA: Liraglutide 6 mg/ml

This page summarises information from the regulator-approved leaflet for reference only. It does not replace the full leaflet, linked on this page, it is not medical advice and it does not replace the assessment of an EU-licensed doctor. Your doctor will review your individual history, dose and interactions during your consultation.

Back to your consultation